{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/44113497"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Fetal hemoglobin switching agents have been proposed to treat genetic blood disorders, such as sickle cell anemia and beta-thalassemia, in an effort to compensate for the dysfunctional form of the beta-globin chain in adult hemoglobin." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "hindawi.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/104724429"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/44113497"] } } }
